I. M. E. Desar, “Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours”, AO, vol. 49, no. 1, pp. 113–116, Jan. 2010.